ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF13.91

F13.91

Billable

Sedative, hypnotic or anxiolytic use, unspecified, in remission

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F13.91 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified, in remission.

Key Diagnostic Point:

F13.91 refers to a condition where an individual has a history of sedative, hypnotic, or anxiolytic substance use disorder but is currently in remission. This means that the individual has not engaged in the problematic use of these substances for a specified period, typically at least 12 months. Sedatives, hypnotics, and anxiolytics include medications such as benzodiazepines and barbiturates, which are often prescribed for anxiety, insomnia, and other conditions. The diagnosis of 'in remission' indicates that the individual has made significant progress in recovery, although they may still experience cravings or psychological symptoms related to their past use. Treatment programs often include behavioral therapies, counseling, and support groups to help maintain remission and prevent relapse. It is crucial for healthcare providers to document the patient's history, treatment progress, and any ongoing support mechanisms to ensure accurate coding and appropriate care.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in documentation of remission status
  • Differentiating between current use and historical use
  • Need for comprehensive patient history
  • Potential overlap with other substance use disorders

Audit Risk Factors

  • Inadequate documentation of remission status
  • Failure to document treatment history
  • Misclassification of active use versus remission
  • Lack of follow-up notes on recovery progress

Specialty Focus

Medical Specialties

Addiction Medicine

Documentation Requirements

Detailed history of substance use, treatment plans, and progress notes.

Common Clinical Scenarios

Patients transitioning from active use to remission, relapse prevention strategies.

Billing Considerations

Ensure that all treatment modalities are documented, including behavioral therapies and support group participation.

Psychiatry

Documentation Requirements

Comprehensive mental health evaluations, treatment history, and ongoing assessments.

Common Clinical Scenarios

Patients with co-occurring mental health disorders and substance use issues.

Billing Considerations

Document any psychiatric medications prescribed and their impact on substance use.

Coding Guidelines

Inclusion Criteria

Use F13.91 When
  • According to ICD
  • 10 guidelines, F13
  • 91 should be used when the patient has a documented history of sedative, hypnotic, or anxiolytic use disorder and is currently in remission
  • Documentation must support the remission status and any ongoing treatment or support

Exclusion Criteria

Do NOT use F13.91 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

H0001CPT Code

Assessment and treatment planning

Clinical Scenario

Used during initial evaluations for patients in remission.

Documentation Requirements

Document the assessment findings and treatment plan.

Specialty Considerations

Addiction specialists should ensure comprehensive evaluations are performed.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of substance use disorders, including remission statuses, which aids in better tracking of patient outcomes and treatment efficacy.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of substance use disorders, including remission statuses, which aids in better tracking of patient outcomes and treatment efficacy.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of substance use disorders, including remission statuses, which aids in better tracking of patient outcomes and treatment efficacy.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What does 'in remission' mean in the context of F13.91?

In the context of F13.91, 'in remission' indicates that the individual has not engaged in problematic use of sedatives, hypnotics, or anxiolytics for a specified period, typically at least 12 months, and is actively participating in recovery efforts.